Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch from IV Epoprostenol to IV Remodulin via Crono Five in PAH
NCT00439946Phase 4Terminated
- Sponsor
- United Therapeutics Corporation
- Start
- Feb 2007
- Primary completion
- Sep 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of treprostinil in pulmonary arterial hypertension (PAH), sponsored by United Therapeutics Corporation. Started Feb 2007; status: terminated.
02
Drugs
treprostinil
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT00439946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00439946.